期刊文献+

多烯磷脂酰胆碱联合异甘草酸镁治疗药物性肝损害疗效观察 被引量:20

Effect of polyene phosphatidylcholine and magnesium isoglycyrrhizinate in the treatment of the drug-induced liver injury
下载PDF
导出
摘要 目的观察多烯磷脂酰胆碱联合异甘草酸镁治疗药物性肝损害的临床疗效。方法观察组以多烯磷脂酰胆碱联合异甘草酸镁治疗药物性肝损害128例,对照组以甘草酸二胺治疗药物性肝损害92例,治疗结束后观察其症状、体征以及肝功能的变化。结果 2周后两组患者丙氨酸氨基转移酶、天门冬酸氨基转移酶及总胆红素较治疗前均明显下降,组内差异有统计学意义(P<0.05),两组之间差异无统计学意义(P>0.05),观察组显效率(75.78%)高于对照组显效率(64.13%),差异有统计学意义(P<0.05)。结论多烯磷脂酰胆碱联合异甘草酸镁可明显改善药物性肝损害的临床症状和肝功能指标,且显效率高,不良反应少。 Objective To explore the effective therapy for therapeutic drug-induced liver injury of polyene phosphatidyl-choline combined magnesium isoglycyrrhizinate. Methods A total of 220 patients with drug-induced liver injury were randomly assigned to receive polyene phosphatidylcholine combined magnesium isoglycyrrhizinate(128 cases,observation group) or diammonium glycyrrhizinate for injection(92 cases,control group) ivgtt qd for 2 consecutive weeks. Results After the treatment for 2 weeks,levels of alanine aminotransferase(ALT),aspartate aminotransferase(AST) and total bilirubin(TB) decreased in both groups(P0.05),but there was no significant difference between two groups(P0.05).The rate of marked improvement (75.78% in treatment group and 64.13%in control group) was significant different(P0.05). Conclusion Polyene phosphatidylcholine and magnesium isoglycyrrhizinate is effective in the treatment of the drug-induced liver injury.
作者 缪进华 范辉
出处 《中国现代医药杂志》 2010年第12期56-58,共3页 Modern Medicine Journal of China
关键词 药物性肝损害 多烯磷脂酰胆碱 异甘草酸镁 甘草酸二胺 Drug-induced liver injury Polyene phosphatidylcholine Magnesium isoglycyrrhizinate Diammonium glycyrrhizinate
  • 相关文献

参考文献8

二级参考文献29

  • 1梅光农.药物性肝炎[J].咸宁学院学报(医学版),2004,18(6):456-456. 被引量:3
  • 2张涛,贾继东.107例药物性肝损害的病因和临床特点[J].肝脏,2005,10(3):174-176. 被引量:40
  • 3邢同京,陈加保,张光曙,甘天福,丁明权,阎承玉.利福平与异烟肼合用致肝损害的临床与病理分析[J].中华结核和呼吸杂志,1997,20(1):33-35. 被引量:80
  • 4Lee WM.Drug-induced hepatotoxicity.N Engl J Med,1995,333:1118-1127.
  • 5Bjornsson E,Olsson R.Outcome and prognostic markers in severe druginduced liver disease.Hepatology,2005,42:481-489.
  • 6Buratti S,Lavine JE.Drugs and the liver:advances in metabolism,toxicity,and therapeutics.Curr Opin Pediatr,2002,14:601-607.
  • 7Spriet-Pourra C,Auriche M,eds.Drug withdrawal from sales.New York:PJB Publications Ltd.1994.23.
  • 8Maria VA,Victorino RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.Hepatology,1997,26:664-669.
  • 9Benichou C.Criteria of drug-induced liver disorders.Report of an international consensus meeting.J Hepatol,1990,11:272-276.
  • 10Sierra F,Torres D.A concise and structured review of drug-induced toxic hepatic disease.Ann Hepatol,2004,3:18-25.

共引文献119

同被引文献185

引证文献20

二级引证文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部